Treatment group | Phys. salt control | Xylene control | One day after esfenvalerate | Two days after esfenvalerate | Seven days after esfenvalerate |
Increase of early component [%] | 45.9 ± 10.1 | 55.9 ± 15.3 | 29.9 ± 19.1 | 62.2 ± 12.9 | 53.8 ± 9.6 |
Increase of late component [%] | 147.3 ± 51.1 | 494.9 ± 263.5 | 200 ± 86.1 | 101.6 ± 38.7 | 187.3 ± 106.7 |
No. of slices with ictal activity | 4/8 | 4/8 | 3/8 | 3/7 | 2/8 |
Latency of first spontaneous activity [min] | 18.58 ± 5.53 | 20.90 ± 5.27 | 26.36 ± 11.39 | 14.94 ± 5.39 | 16.77 ± 3.62 |
Latency of first ictal activity [min] | 28.80 ± 6.08 | 44.96 ± 7.89 | 28.97 ± 14.05 | 20.13 ± 10.50 | 36.75 ± 4.15 |
No. of ictal episodes | 2.88 ± 1.94 | 1.88 ± 1.55 | 2.43 ± 2.42 | 5.86 ± 5.59 | 0.88 ± 1.28 |
No. of interictal episodes | 12.88 ± 11.70 | 17.25 ± 16.54 | 1.25 ± 1.06 | 53.60 ± 20.41 | 27.14 ± 12.50 |
Frequency of spontaneous episodes [1/min] | 0.65 ± 0.12 | 0.96 ± 0.11 | 0.43 ± 0.03 | 2.30 ± 0.96 | 1.17 ± 0.37 |